Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: results of a phase II study. [electronic resource]
Producer: 20121130Description: 408-14 p. digitalISSN:- 1873-2496
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Hormonal -- adverse effects
- Diarrhea -- chemically induced
- Drug Administration Schedule
- Enzyme-Linked Immunosorbent Assay
- Fatigue -- chemically induced
- Flatulence -- chemically induced
- Humans
- Insulin-Like Growth Factor Binding Protein 1 -- blood
- Insulin-Like Growth Factor Binding Protein 3 -- blood
- Insulin-Like Growth Factor I -- analysis
- Insulin-Like Growth Factor II -- analysis
- Male
- Middle Aged
- Octreotide -- adverse effects
- Orchiectomy
- Peptides -- blood
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.